Results of randomized phase II trial of neoadjuvant carboplatin plus docetaxel or carboplatin plus paclitaxel followed by AC in stage I-III triple-negative breast cancer (NCT02413320).

Sharma, Priyanka, Kimler, Bruce F., O'Dea, Anne · Journal of Clinical Oncology · 2019